Key Takeaways from SCOPE 2025: Insights from Cromos Pharma’s US Business Development Director With the conclusion of the 16th Annual Summit for Clinical Operations Executives (SCOPE) held from February 3-6, 2025, in Orlando, industry experts shared key insights into the future of clinical research and development. This year’s discussions centered on artificial intelligence, decentralized clinical trials (DCTs), localization, and strategies for improving efficiency and diversity in clinical trials. Read more
Clinical Research Focus. 37th Edition Reflections from JPM 2025: A CEO’s Perspective on Biopharma’s New Era Having just returned from the 2025 JP Morgan Healthcare Conference, I am energized by the transformative developments shaping the biopharma industry. With over 8,000 professionals in attendance and more than 500 companies presenting, the conference underscored the resilience, creativity, and forward-thinking Read more
World Cancer Day 2025: How Clinical Trials Are Shaping the Future of Cancer Treatment On this World Cancer Day, we reflect on the progress made in the fight against cancer and the challenges ahead. With over 2 million new cases diagnosed in the US in 2024 alone, cancer remains a leading cause of death. However, breakthroughs in early detection, targeted therapies, and clinical trial innovations are reshaping oncology care. Read more
The Optimus Revolution: Four Years of Progress in Oncology Drug Development In 2021, the FDA’s Oncology Center of Excellence launched the Project Optimus initiative, a groundbreaking effort designed to transform the approach to dose optimization in oncology drug development. The focus shifted from merely identifying the maximum tolerated dose (MTD) to exploring the optimal biological dose (OBD), promising more effective and less toxic treatments. Over the Read more
